Beijing Wuhe Boao Pharmaceutical Co., Ltd.
PrivateLast Round
Series B
Extension
Sep 1, 2025
Est. Valuation
$562.09M
Total Funding Raised
$216.56M
Company Overview
Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a biopharmaceutical company that develops natural drug innovations and advanced drug delivery systems for the treatment of metabolic disorders, malignant tumors, and inflammatory-immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Wuhe Boao Pharmaceutical Co., Ltd. Comparables
Compare Beijing Wuhe Boao Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hua Medicine | 80% | |
| Luye Pharma Group | 76% | |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | 74% |
Beijing Wuhe Boao Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 1, 2025 | ||||
| Series C | Nov 4, 2024 | ||||
| Series B | Dec 24, 2020 | ||||
| Series A | Sep 1, 2015 | ||||
| Series A Extension | Jun 1, 2015 |
Beijing Wuhe Boao Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B, Series B Extension |
| Northern Light Venture Capital | Series B Extension, Series A Extension |
| Lang Sheng Investment | Series B Extension |
| Cowin Capital | Series B Extension, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
$63M round with Cathay Capital and Cowin Capital
Beijing Wuhe Boao Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Wuhe Boao Pharmaceutical Co., Ltd. a public or private company?
Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Beijing Wuhe Boao Pharmaceutical Co., Ltd.?
Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Wuhe Boao Pharmaceutical Co., Ltd. worth (valuation)?
Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s valuation is estimated at $562.1M based on funding round data.
Can I buy Beijing Wuhe Boao Pharmaceutical Co., Ltd. stock?
Beijing Wuhe Boao Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s last funding round?
Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s most recent funding round was Series B Extension on September 1, 2025.
Who are the main investors in Beijing Wuhe Boao Pharmaceutical Co., Ltd.?
Key investors in Beijing Wuhe Boao Pharmaceutical Co., Ltd. include Cathay Capital, Northern Light Venture Capital, Lang Sheng Investment, Cowin Capital.
Will Beijing Wuhe Boao Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Wuhe Boao Pharmaceutical Co., Ltd..
How can I track Beijing Wuhe Boao Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s shares on secondary markets.